Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2618 of 5804
-
Live bacteria cream shows promise for rare skin disease
Disease control Recruiting nowThe objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to ATR12-351, and to observe treatment benefits of the drug in approximately 12 adult patients with Netherton Syndrome (NS). ATR12-35…
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Experimental CAR t therapy targets tough myeloma cases
Disease control TerminatedThis is a Phase I dose-escalation study to evaluate the safety, tolerability and preliminary efficacy of an autologous BCMA-targeting RNA-engineered CAR T-cell therapy in patients with Relapsed/Refractory Multiple Myeloma. The cell product is referred to as Descartes-15
Phase: PHASE1 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can telehealth ease the burden for families of medically complex kids?
Symptom relief Recruiting nowChildren with medical complexity (CMC) have very high needs for health and support services. CMC have very rare diseases that involve multiple organ systems. As a result, all CMC have multiple chronic conditions and need care from many specialists and services. While there are im…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Horses may ease anxiety for young cancer patients
Symptom relief Recruiting nowThis study proposes a horse-assisted therapy (HAT) approach to accompany children and young adults undergoing irradiation in the ICANS Radiotherapy Department. The aim of this new approach is to improve quality of life and reduce anxiety in children and adolescents treated with …
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New gel blocks blood flow to tumors and stops bleeding
Disease control CompletedOCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Sleep therapy may curb risky behavior in teens with insomnia
Symptom relief Recruiting nowInsomnia is prevalent in adolescents. Impulsive behaviours and excessive risk-taking have been linked to the manifestation of psychopathology in youths. Previous research based on behavioural and neurophysiological measures has found that individuals with insomnia demonstrated im…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Brain zaps for anxiety? small study tests new target
Symptom relief CompletedThe present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.
Phase: NA • Sponsor: Shanghai Mental Health Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Pushing a weighted sled may help cancer patients build muscle and lose fat
Disease control OngoingThis protocol seeks to analyze patient adherence and outcomes after monitored exercise sessions utilizing primarily weighted sled pushes and pulls for linearly progressed resistance training of individuals who have been diagnosed with cancer.
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New cancer drug AMT-676 enters first human tests
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter Phase Ia/Ib study of AMT- 676, followed by an open-label, multicenter, dose-escalation.
Phase: EARLY_PHASE1 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New antibody takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study is to evaluate a novel cytotoxic anti-PD-L1, IUAb190708, for the treatment of tumor
Phase: PHASE1 • Sponsor: Jun Zhou • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could your own blood cells tame MS? early trial shows promise
Disease control CompletedRED4MS is a clinical trial to assess the safety and tolerability of autologous peptide coupled red blood cells (CLS12311) in patients with relapsing remitting multiple sclerosis (RRMS). CLS12311 consists of autologous red blood cells (RBCs) coupled with antigenic peptides and aim…
Phase: PHASE1 • Sponsor: Cellerys AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
No more needles? new scans could replace kidney biopsies
Diagnosis Recruiting nowIn this study, the condition of the kidney transplant in adults is to be assessed non-invasively using Multispectral Optoacoustic Tomography and Ultrasound Localization Microscopy (ULM). ULM imaging can be performed in a 2-dimensional and a 3-dimensional way (2D and 3D ULM). Ther…
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Text messages could help latino diabetes patients stick to meds
Disease control CompletedLatino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a shot in the good leg stop phantom pain?
Symptom relief Recruiting nowThis research is being done to determine if an anesthetic like Lidocaine, may be effective when injected around the sciatic nerve of the intact limb in patients with limb loss pain on the contralateral side.
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New study tests whether community helpers and trauma training can boost kidney care for minorities
Knowledge-focused CompletedBlack and Hispanic people face higher risks of chronic kidney disease (CKD) but have unequal access to the highest-quality kidney care. Black adults with CKD face 1.5 times higher hospitalization risks than non-Black adults with CKD. Once reaching end stage kidney disease (ESKD),…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Ear acupuncture offers hope for breast cancer patients suffering hot flashes
Symptom relief CompletedWith this clinical trial we investigate whether auricular acupuncture during adjuvant endocrine therapy has an improving effect on hot flashes, which are often perceived as psychologically and physically stressful in self-assessment of women with breast cancer. Empirical studies…
Phase: NA • Sponsor: Kliniken Essen-Mitte • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New asthma drug shows promise in Real-World spanish study
Disease control CompletedThe aim of this study is to provide the first results on the use of tezepelumab under clinical practice conditions in severe asthma patients who participated in the "foreign medication supply" program in Spain.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple supplement speed up fracture recovery in seniors?
Disease control Recruiting nowThis trial will evaluate the impact of 4 weeks of postoperative essential amino acid (EAA)-based supplementation on muscle morphology after femoral fragility fracture. This trial will assess the ability of EAA-based to increase skeletal muscle metabolic activity, reduce inflammat…
Phase: PHASE2 • Sponsor: Michael C Willey • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can THC ease your aching back? new study seeks answers
Symptom relief Recruiting nowThis exploratory, proof-of-concept study is a double-blind (participants and investigators will be blinded), placebo-controlled, randomized, two-arm clinical trial of Marinol \[dronabinol, synthetic Δ9-tetrahydrocannabinol (THC)\] for chronic low back pain (cLBP) with a 2:1 alloc…
Phase: PHASE2 • Sponsor: Christopher D. Verrico • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New torsemide formulation aims to ease bladder symptoms in heart failure
Symptom relief CompletedThis research study is being done to compare the effectiveness two drugs: an Extended Release Torsemide (ERT) versus generic Immediate Release Torsemide (IRT) in reducing the worsening of symptoms of Overactive Bladder (OAB, i.e., frequency, urgency, or urgency incontinence) in p…
Phase: PHASE2 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC